Abstract:Background Altered expression of astrocyte elevated gene-1 (AEG-1) is associated with tumorigenesis and progression. The present study aimed to investigate the clinical and prognostic significance of AEG-1 expression in pancreatic ductal adenocarcinoma (PDAC). Methods Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and Western blot analyses were employed to assess AEG-1 expression in three pancreatic cancer cell lines and normal pancreatic duct epithelial cells. qRT-PCR and immunohistochemical analyses were performed to detect AEG-1 expression in ten pairs of PDAC and normal pancreas tissues. Immunohistochemistry was then used to examine AEG-1 expression in paraffin-embedded tissues obtained from 105 patients, and its association with clinicopathological parameters including cancer classification was examined. Kaplan-Meier analysis was performed to study the survival rates of patients. Results Expression of AEG-1 mRNA and protein was markedly higher in pancreatic cancer cell lines than that in the normal pancreatic duct epithelial cells. AEG-1 expression was evidently upregulated in PDAC tissues compared to that of the matched distant normal pancreas tissues. qRT-PCR data revealed that the tumor/non-tumor ratio of AEG-1 expression was >1.5-fold (up to 6.5-fold). Immunohistochemical data showed that AEG-1 protein was detected in 98.09% (103/105) of PDAC tissues; and they were found to be associated with tumor size ( P = 0.025), advanced clinical stage ( P = 0.004), T classification ( P = 0.006), N classification ( P = 0.003), and M classification ( P = 0.007). Furthermore, Kaplan-Meier analysis showed that patients with high AEG-1-expressed PDAC had shorter overall survival. A multivariate Cox regression analysis revealed that clinical stage, T classification, and AEG-1 expression were the independent prognostic predictors for PDAC. Conclusions This study suggests that AEG-1 protein was highly expressed in PDAC and associated with poor prognosis of the patients.

Down-regulation of astrocyte elevated gene-1 expression inhibits the proliferation and invasion of human bladder cancer T24 cells

Depletion of Astrocyte Elevated Gene-1 Suppresses Tumorigenesis Through Inhibition of Akt Activity in Bladder Cancer Cells.

Downregulation of Angiogenin Inhibits the Growth and Induces Apoptosis in Human Bladder Cancer Cells Through Regulating AKT/mTOR Signaling Pathway.

Small Interfering RNA Targeting REG1A Gene Inhibits the Proliferation of Human Bladder Cancer Cell Line T24 in Vitro

Inhibition of TGF-β by siRNA Suppresses the Motility and Invasiveness of T24 Bladder Cancer Cells

AEG-1 is associated with tumor progression in nonmuscle-invasive bladder cancer

Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance.

Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells

Effect of IGHG1 gene on cell migration,proliferation and apoptosis of bladder cancer cells

The Down-Regulation of SNCG Inhibits the Proliferation and Invasiveness of Human Bladder Cancer Cell Line 5637 and Suppresses the Expression of MMP-2/9.

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

Effect of silencing LRIG3 gene on the proliferation and apoptosis of bladder cancer T24 cells

RNA Interference Targeting Regenerating Islet-Derived 1 Alpha Gene Inhibits Cell Proliferation and Decreases Invasion of Human Bladder Cancer Cell Line EJin Vitro

Effect of Silencing Notch1 on Proliferation of Bladder Cancer Cell Line T24

Decreased REG1α Expression Suppresses Growth, Invasion and Angiogenesis of Bladder Cancer.

Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification

Impact of CCDC34 down-regulation on the proliferation, migration and invasion of bladder cancer cell

Effect of Notch1 on Biological Behavior of Bladder Cancer Cells

CRYAB Inhibits Migration and Invasion of Bladder Cancer Cells Through the PI3K/AKT and ERK Pathways.

Influence of estrogen receptor a on proliferation and metastasis in bladder cancer cells

RNA Interference-Mediated Vascular Endothelial Growth Factor-C Reduction Suppresses Malignant Progression and Enhances Mitomycin C Sensitivity of Bladder Cancer T24 Cells